首页> 外文期刊>European journal of clinical pharmacology >Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome
【24h】

Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome

机译:他克莫司和小ber碱在特发性肾病综合征患儿中的药代动力学相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

Berberine is a major isoquinoline alkaloid in herbs such as goldenseal, berberis, and Coptis chinensis and has been traditionally used to treat diarrhea [1]. We report here a well-documented interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome. A 16-year-old child was confirmed to have nephrotic syndrome after observation of 1-month history of generalized edema associated with persistent proteinuria in April 2012. The immunosuppressive therapy was initialed with prednisone (60 mg/m~2/day), frequent relapses occurs when prednisone dose was reduced to 40 mg/m~2/day. Tacrolimus (0.1 mg/kg, twice daily) was then added to immunosuppressive therapy. Tacrolimus dosage adjustment was based on therapeutic drug monitoring (TDM) in order to maintain trough blood concentration (Co) in the therapeutic range of 5-15 ng/mL [2].
机译:小ber碱是黄s,小ber和黄连等草药中的主要异喹啉生物碱,传统上已用于治疗腹泻[1]。我们在这里报告了他克莫司和小ber碱在特发性肾病综合症患儿中的有据可查的相互作用。在2012年4月观察到1个月的持续性蛋白尿相关的广泛性水肿病史后,确认一名16岁儿童患有肾病综合症。免疫抑制剂治疗开始于泼尼松(60 mg / m〜2 / day),频繁当泼尼松剂量降至40 mg / m〜2 / day时,复发发生。然后将他克莫司(0.1 mg / kg,每天两次)添加到免疫抑制治疗中。他克莫司的剂量调整基于治疗药物监测(TDM),以将低谷血药浓度(Co)维持在5-15 ng / mL的治疗范围内[2]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号